Multiple quantum filtered 23Na NMR in the Langendorff perfused mouse heart: Ratio of triple/double quantum filtered signals correlates with [Na]i  by Eykyn, Thomas R. et al.
Journal of Molecular and Cellular Cardiology 86 (2015) 95–101
Contents lists available at ScienceDirect
Journal of Molecular and Cellular Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate /y jmccOriginal articleMultiple quantum ﬁltered 23Na NMR in the Langendorff perfused mouse
heart: Ratio of triple/double quantum ﬁltered signals correlates
with [Na]i
Thomas R. Eykyn a,b,⁎,1, Dunja Aksentijević b,1, Karen L. Aughton b, Richard Southworth a,b,
William Fuller c, Michael J. Shattock b
a Department of Imaging Chemistry and Biology, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital,
London SE1 7EH, United Kingdom
b The British Heart Foundation Centre of Research Excellence, The Rayne Institute, King's College London, St. Thomas' Hospital, London SE1 7EH, United Kingdom
c Division of Cardiovascular and Diabetes Medicine, University of Dundee, Dundee, United Kingdom⁎ Corresponding author at: Department of Imaging Che
Imaging Sciences and Biomedical Engineering, King's
Partners, St. Thomas' Hospital, London SE1 7EH, United K
E-mail address: thomas.eykyn@kcl.ac.uk (T.R. Eykyn).
1 Authors contributed equally.
http://dx.doi.org/10.1016/j.yjmcc.2015.07.009
0022-2828/© 2015 The Authors. Published by Elsevier Ltda b s t r a c ta r t i c l e i n f oArticle history:
Received 21 March 2015
Received in revised form 8 July 2015
Accepted 10 July 2015
Available online 18 July 2015
Keywords:
Multiple quantum ﬁltered 23Na
TQF
DQF
Langendorff perfused mouse heart
Shift reagentWe investigate the potential of multiple quantum ﬁltered (MQF) 23Na NMR to probe intracellular [Na]i in the
Langendorff perfused mouse heart. In the presence of Tm(DOTP) shift reagent the triple quantum ﬁltered
(TQF) signal originated largely from the intracellular sodium pool with a 32 ± 6% contribution of the total TQF
signal arising from extracellular sodium, whilst the rank 2 double-quantum ﬁltered signal (DQF), acquired
with a 54.7° ﬂip-angle pulse, originated exclusively from the extracellular sodium pool. Given the different cellu-
lar origins of the 23NaMQF signalswepropose that the TQF/DQF ratio can be used as a semi-quantitativemeasure
of [Na]i in the mouse heart. We demonstrate a good correlation of this ratio with [Na]i measured with shift re-
agent at baseline and under conditions of elevated [Na]i. We compare the measurements of [Na]i using both
shift reagent and TQF/DQF ratio in a cohort of wild typemouse hearts and in a transgenic PLM3SAmouse express-
ing a non-phosphorylatable form of phospholemman, showing a modest but measurable elevation of baseline
[Na]i. MQF ﬁltered 23Na NMR is a potentially useful tool for studying normal and pathophysiological changes in
[Na]i, particularly in transgenic mouse models with altered Na regulation.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Intracellular Na concentration [Na]i is a keymodulator of cardiac cell
function [1]. At steady-state [Na]i has been measured between 4–
16mM depending on species and preparation [2]. The Na electrochem-
ical gradient across the cell membrane provides the energy for the ac-
tion potential upstroke, as well as the active transport of many other
ions, amino acids and substrates into the cell [2,3]. [Na]i is also critical
for the control of intracellular calcium [Ca]i via the sodium–calcium ex-
changer (NCX), thereby determining sarcoplasmic reticulum (SR) Ca
content and cardiac contractility [4]. Maintenance of the Na+ gradient
is therefore fundamentally important in normal physiology but is also
critically important in cardiac hypertrophy and heart failure where the
elevation of [Na]i contributes to contractile and electrical dysfunction
[5–7].mistry and Biology, Division of
College London, King's Health
ingdom.
. This is an open access article underHistorically, many techniques have been used tomeasure intracellu-
lar Na but few are physiologically relevant, eithermeasuringNa at room
temperature or in quiescent preparations [1]. 23Na nuclear magnetic
resonance (NMR) is able to distinguish intra versus extracellular Na
pools, employing paramagnetic shift reagents such as Tm(DOTP) [8] to
separate the two. However, these reagents are efﬁcient chelators of Ca
and Mg leading to modiﬁed ion homeostasis and reduced cardiac con-
tractility [9]. As a result, shift reagents exhibit signiﬁcant toxicity pre-
cluding their use in vivo. In contrast, multiple quantum ﬁltered (MQF)
23Na nuclear magnetic resonance has shown great potential to probe
intra and extracellular pools of Na in the absence of shift reagent and
therefore under more physiological conditions [10,11]. Much work has
been carried out developing multiple quantum ﬁltered 23Na NMR in
the perfused rat heart [10,12,13], in vivo in skeletal muscle and the
brain [14] and in tumours [15]. In the perfused rat heart, the 23Na TQF
signal has contributions from the intra and extracellular Na pools [11,
12,16] andhas been shown to be proportional to intracellular [Na]imea-
sured by atomic absorption spectroscopy [13]. Methods have been de-
veloped to suppress the extracellular contribution to the TQF signal
[17]. On the other hand, the 23Na DQF signal was found previously to
arise only from the extracellular Na pool in the rat heart suggestingthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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partments [18].
Whilst the isolated rat heart has historically been an important
model for cardiovascular research, the ability to rapidly and efﬁciently
manipulate the genomeof themouse has recentlymade this the species
of choice for many physiological and biochemical studies. The applica-
tion of MQF 23Na NMR techniques to the isolated perfused mouse
heart is much more challenging due to technical issues of the smaller
heart size and, prior to this study, has not been described. The aim of
the present study was therefore to revisit the utility of the multiple
quantum ﬁltered experiment and to establish and characterise the
methods necessary to apply MQF 23Na NMR measurements to isolated
Langendorff-perfused mouse hearts in both wild-type and a transgenic
PLM3SA genotype displaying altered [Na]i homeostasis. The PLM3SA
transgenic mouse has three mutations of the PLM phosphorylation
sites Ser63, 68 and 69 which have been substituted for alanine, render-
ing PLM unphosphorylatable, leading to altered Na/K ATPase activity
and elevated intracellular Na [6].
2. Methods
2.1. Langendorff mouse heart perfusion
C57BL/6J male mice (~28 g bodyweight) were purchased fromHar-
lan (Harlan, UK). PLM3SA andWTmicewere bred ‘in house’ as previous-
ly described [6]. Mice were kept in individually ventilated cages with a
12 h light–dark cycle, controlled humidity and temperature (20–
22 °C), fed standard chow and water ad libitum. All experiments were
approved by institutional ethical review committee and conform to
theUKHomeOfﬁce Guidance on theOperation of the Animals Scientiﬁc
Procedures Act 1986 (HMSO).
Mice were administered terminal anaesthesia via intra-peritoneal
pentobarbitone injection (~140 mg/kg body weight). Hearts were rap-
idly excised, cannulated and perfused in isovolumic Langendorff mode
and perfused at 80 mm Hg pressure maintained by a STH peristaltic
pump controller feedback system (AD Instruments, Oxford, UK), at
37 °C with Krebs–Henseleit (KH) buffer continuously gassed with 95%
O2/5%CO2 (pH 7.4) containing (inmM):NaCl 116, KCl 4.7,MgSO4·7H2O
1.2, NaHCO3 25, KH2PO4 1.4, CaCl2 1.4, glucose 11 [19]. Cardiac function
was assessed using aﬂuid-ﬁlled cling-ﬁlm balloon inserted into left ven-
tricle (LV), and connected via a rigid polyethylene line to an MR-
compatible pressure transducer (DTX Plus TNF-R, Becton-Dickinson)
and a PowerLab system (AD Instruments, Australia). The volume in
the intraventricular balloon was adjusted using a 1.0 ml syringe to
achieve an initial LV diastolic pressure of ~9mmHg. Left ventricular de-
veloped pressure (LVDP) was calculated from the difference between
systolic (SP) and diastolic pressures (DP). Functional parameters (sys-
tolic pressure, end-diastolic pressure, heart rate, LVDP, coronary ﬂow,
perfusion pressure) were monitored using LabChart software v.7 (AD
Instruments, Australia) throughout the experiment [19].
The low ﬂow rates and the long perfusion lines in NMR systems can
create problems with adequate temperature control. In addition, these
long perfusion lines create signiﬁcant ‘dead-spaces’ (where tempera-
ture, gas solubility and pH may change) and introduce long delays on
switching solutions. These problems were solved in the current system
by the use of two parallel continuously recirculating water-jacketed
perfusion lines (Fig. 1a). Control, and test solutions were gassed at
37 °C before being pumped (Gilson Minipuls 3) through two parallel
lines within a water-jacketed (37 °C) umbilical line (approx 3 m in
length). These two lines then enter a novel three-way pneumatically
operated valve positioned directly above the cannula (Fig. 1a). Control
solution was passed via the pneumatic valve to the heart whilst the
test solution was recirculated back up the umbilicus to the external res-
ervoir. When the valve is activated, the control solution is recirculated
and the test solution passes to the heart with effectively no distal stag-
nant dead-space and a switching time of b2 s, at the level of the heart.In order to protect the magnet, coils etc. from accidental leakage, the
perfusion system includes a ‘ﬂood plain’ between the perfusion lines,
valve etc. and the cannula (Fig. 1a). This ﬂood plain includes a moisture
sensor connected to a remote alarm. The umbilical line, transducers,
valve and all ﬁttings were manufactured exclusively of non-magnetic
parts and was fed via the top of themagnet and lowered into the active
region of the bore/microimaging coil. At the end of each experiment, the
perfusion system was removed from the magnet and hearts were im-
mediately snap frozen using Wollenberger tongs, pre-cooled in liquid
nitrogen, and wet and dry weights were recorded.
2.2. NMR spectroscopy
All experiments were carried out on a Bruker Avance III 400 MHz
wide-bore spectrometer (Bruker, Karlsruhe, Germany) equipped with
triple-axis gradients, amicroimagingprobe and exchangeable RF coil in-
serts (10 mm 23Na coil or 1H/31P dual tune coil) that enable rapid
switching between different nuclei. NMR tubes (O.D. 10mm) (Wilmad,
UK) were shortened in length to just greater than the NMR active coil
region in order to minimize the perfusate dead volume beneath the
heart. The bore of the NMRwasmaintained (~313 K) by continuous de-
livery of warm water, from a thermostatically controlled water bath,
through the imaging gradients of the MR. Temperature calibration was
performed in situ using a capillary containing ethylene glycol at the
position of the heart.
To analyse the relationship between [Na]i elevation and TQF and
DQF signal intensities, hearts were equilibrated for 20 min, followed
by 20min treatment with: (i) standard KHB (n= 6) (ii) 50 μMouabain
(n= 6), (iii) K+-free buffer (n = 3), (iv) K+-free/Ca2+-free (n= 3) or
(v) K+-free/Ca2+-free/Mg2+-free (n = 3) buffer. Interleaved TQF and
DQF NMR acquisitions were recorded throughout the stability period
and during the intracellular sodium elevation protocols. At the end of
each intervention, perfusate was switched to KHB containing 5 mM
Tm(DOTP)5− to shift the extracellular [Na]e signal and quantify [Na]i.
An intracellular volume of 2.5 ml/g dry weight of tissue was assumed
for calculation of [Na]i [20].
In order to conﬁrm that cardiac energetics were normal and not
compromised prior to any elevation in [Na]i, fully relaxed 31P experi-
ments were also performed with the same perfusion system and phos-
phate free Krebs–Henseleit buffer, acquired with a 60° ﬂip angle, 256
scans, a repetition time of 3.8 s and a total experiment duration of
16 min.
2.3. Multiple quantum ﬁltered 23Na MRS
The multiple quantum ﬁltered pulse sequence consists of [10]:
90°(ϕ1)− τm /2−180°(ϕ2)− τm /2−β°(ϕ2)− δ−β°(ϕ3)− FID(ϕrec).
DQF experiments were acquired with a four-step phase cycle: ϕ1 =
ϕ2 = 90°, 180°, 270°, 0°; ϕ3 = 0°; ϕrec = 0°, 180°, 0°, 180°. The ﬂip
angle β was set either to the magic angle, 54.7° (rank 2 T2,±2 only) or
to 90° (both rank 2 T2,±2 and rank 3 T3,±2). TQF experiments were ac-
quired with a six-step phase cycle: ϕ1 = 30°, 90°, 150°, 210°, 270°,
330°; ϕ2 = 120°, 180°, 240°, 300°, 0°, 60°; ϕ3 = 0°; ϕrec = 0°, 180°,
0°, 180°, 0°, 180° with the ﬂip angle β = 90° (rank 3 T3,±3 only). The
mixing time (τm= 3.6 ms) was calibrated for themaximum TQF signal
in the mouse heart and set to be the same for the DQF experiments. All
MQF experiments were acquired with 192 scans, 2048 data points,
sweep width of 50 ppm, an acquisition time of 200 ms, pre-scan delay
of 200 ms and a total acquisition time of 1.24 min. An exponential line
broadening factor of 10 Hz was applied prior to Fourier transformation
and subsequent baseline correction.
2.4. Shift reagent 23Na MRS
All hearts were perfused at the end of the protocol with modi-
ﬁed KHB containing 5 mM Tm(DOTP)5− (thulium (III) 1,4,7,10-
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Fig. 1. NMR compatible Langendorff constant pressure perfusion system (a, b) and a schematic of the pneumatically driven three-way valve to allow switching between reservoirs with
minimum dead-volume (c).
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(Macrocyclics, Dallas, USA) gassed with 95% O2/5% CO2 (pH 7.4) con-
taining (in mM): NaCl 116, KCl 4.7, MgSO4.7H2O 1.2, NaHCO3 25,
KH2PO4 1.4, CaCl2 1.4, glucose 11. Due to the Ca chelating effect of
Tm(DOTP)5−, [Ca]free was measured by blood gas analyser which was
below detection limit, corresponding to almost complete chelation of
free Ca by the DOTP ligand. 23Na acquisitions were recorded in real-
time during the perfusion with the shift reagent until the extracellular
[Na]e peakwas completely shifted (5–10min) (Fig. 2b). Following infu-
sion of shift reagent a single quantum spectrumwas acquired with 128
scans, 2048 data points, sweep width of 50 ppm, an acquisition time of
200ms, pre-scan delay of 200ms and a total acquisition time of 50 s. An
exponential line broadening factor of 10 Hzwas applied prior to Fourier
transformation and subsequent baseline correction. The resulting [Na]i
peak was referenced to a glass bulb containing 2.9 μmol NaCl with
10 mM Tm(DOTP)5− at the position of the heart. The Na present in
the calibration bulb was assumed to be 100% NMR visible ie fo = 1.0.
The visibility of intracellular Na is more controversial but, in these stud-
ies, was assumed to be fi=0.4 and thiswas assumed to remain constant
throughout the experimental protocol. [21–23].
2.5. Statistical analysis
Data were analysed and expressed as mean ± standard error of the
mean (SEM), n = number of independent experiments. Where appro-
priate, statistical analysis was performed using Students t-test andrelationship between variables analysed using Pearson correlation.
P b 0.05 was considered statistically signiﬁcant.
3. Results
Table 1 shows functional data at 5 min intervals during the 20 min
stability period. Averaged over the 20 min period (±SEM), systolic
pressure was 107 ± 6 mm Hg, end diastolic pressure (EDP) was 11 ±
2 mm Hg, left ventricular developed pressure (LVDP) was 96 ±
15 mm Hg, heart rate (HR) was 455 ± 66 bpm and coronary ﬂow was
2.3 ± 0.2 ml/min.
Fig. 2(a) shows a representative 31P spectrum acquired in the
mouse heart at baseline prior to intervention and is representative
of normal cardiac energetics displaying resonances from adenosine
triphosphate (ATP), phosphocreatine (PCr) and inorganic phosphate
(Pi). Fig. 2(b) shows a time-course of 23Na spectra acquired during
perfusion with Tm(DOTP)5−. In the absence of shift reagent (time =
0) the total Na peak corresponds to the sumof contributions from intra-
cellular [Na]i, extracellular/intravascular [Na]e, and from buffer sur-
rounding the heart [Na]o. During infusion of shift reagent the 23Na
signal from the extracellular/intravascular [Na]e pool is shifted ﬁrst
and at later times (5–10 min) mixing of buffer surrounding the heart
is achieved.
Fig. 3(a) shows the single quantum 23Na NMR spectrum acquired
after infusion of shift reagent where an unshifted Na signal arising
from the intracellular [Na]i pool, can readily be discerned and
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Fig. 2. (a) Example 31P spectrum acquiredduring baseline stability period showingnormal
cardiac energetics. (b) Time-series of 23Na NMR spectra acquired in a perfused mouse
heart during the infusion of Tm(DOTP) shift reagent. An initial shift of the intravascular ex-
tracellular signal [Na]e is observed, followed by the signal from the buffer surrounding the
heart [Na]o was achieved within a 5–10 min timeframe.
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Fig. 3. (a) 23Na single quantum spectrumpost-infusion of shift reagentwhere the intracel-
lular peak from [Na]i is clearly discerned. (b) TQF spectrum acquired from the same heart
as in (a) in the presence of shift reagent showing predominantly intracellular [Na]i with a
smaller contribution from extracellular [Na]e. (c) 23Na DQF spectrum acquired with a ﬂip
angle β = 54.7° showing predominantly extracellular [Na]e. (d) 23Na DQF spectrum
acquired with a ﬂip angle β= 90° showing both intracellular and extracellular Na.
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in the presence of shift reagent where the positions of the relevant
peaks are denoted by dashed lines. Fig. 3(b) shows the TQF signal arising
principally from the intracellular [Na]i pool with a smaller contribution
from the extracellular pool. The contribution to the total TQF signal aris-
ing fromNae acquiredwith shift reagent was Nae/(Nae+Nai)= 0.32±
0.06 (S.E. n= 6) corresponding to 32% of the total TQF signal. That is, in
these experiments, 68% of the TQF signal reﬂects intracellular Na whilst
32% of the signal comes from extracellular sources. Fig. 3(c) shows the
DQF spectrum acquired with shift reagent and a ﬂip angle β = 54.7°
showing exclusively extracellular Nae. Intracellular sodium was not ob-
served employing the DQF sequence with a magic ﬂip angle pulse.
Fig. 3(d) shows the DQF spectrum acquired with shift reagent and a
ﬂip angle β= 90° showing both intracellular and extracellular Na and
was not used further in this work due to a mixed contribution from
both intra and extracellular Na pools.
Fig. 4(a) shows the amplitude of the TQF andDQF signals acquired in
an interleaved fashion during 20 min stabilisation period and during
20 min infusion of 50 μM ouabain. Representative 23Na TQF and DQF
spectra are shown in Fig. 4(b) during baseline stability, (c) afterTable 1
Cardiac function acquired at 5 min intervals during the 20 min stability period.
Functional
parameters
Time (min)
(n = 7) 0 5 10 15 20
Systolic pressure
(mm Hg)
109 ± 12 113 ± 11 103 ± 17 103 ± 19 106 ± 19
EDP (mm Hg) 11 ± 1 9 ± 2 11 ± 2 10 ± 2 12 ± 2
LVDP (mm Hg) 98 ± 12 104 ± 11 92 ± 16 93 ± 18 93 ± 19
Heart rate (bpm) 382 ± 32 526 ± 54 453 ± 67 449 ± 79 464 ± 96
Coronary ﬂow
(ml/min)
2.2 ± 0.1 2.2 ± 0.2 2.4 ± 0.2 2.2 ± 0.2 2.6 ± 0.2
EDP — end diastolic pressure, LVDP — left ventricular developed pressure.20 min infusion of ouabain (d) after 20 min K+-free buffer and
(e) after 20 min K+-free/Ca2+-free buffer. A signiﬁcant increase in the
TQF signal was observed with respect to the baseline TQF signal with
minimal changes in the DQF signal. The increase in [Na]i is consistent
with the mode of action of ouabain and blocking of the Na/K ATPase
or inhibition of Na efﬂux using modiﬁed buffers.
Fig. 5 shows a plot of the ratio of the TQF/DQF signals (RTQF/DQF) as a
function of [Na]i measured with shift reagent, in control hearts at base-
line [Na]i and in the four groups displaying elevated [Na]i after treat-
ment with 50 μM ouabain (n = 6); K+-free (n = 3), K+-free/Ca2+-
free (n = 3) and K+-free/Ca2+-free/Mg2+-free (n = 3). The mean
RTQF/DQF was 3.0 ± 0.3 for control hearts, 4.4 ± 0.7 for 50 μM ouabain
treatment, 5.2 ± 1.1 for K+-free hearts, 7.7 ± 1.1 for K+-free/Ca2+-
free and 6.3 ± 0.4 for K+-free/Ca2+-free/Mg2+-free with a measured
[Na]i = 15.7 ± 1.6 mM; 25.5 ± 5.8 mM; 40.0 ± 5.7 mM, 57.9 ±
2.4mMand 54.9± 6.5mM, respectively. RTQF/DQF showed a good corre-
lation with [Na]i. The intercept on the y-axis demonstrates a non-zero
RTQF/DQF at [Na]i = 0 mM conﬁrming that there is a non-zero contribu-
tion from [Na]e to the TQF signal. From this line of ﬁt, intracellular Na
can be estimated from a measured RTQF/DQF according to the equation:
[Na]i= (RTQF/DQF− 1.42) / 0.10. This suggests that the extracellular con-
tribution to the TQF signal is ~47%, therefore slightly greater than the
32% contribution estimated earlier in the presence of shift reagent, but
lower than previously reported values for the rat heart of ~64% [13].
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Fig. 4. (a) Peak areas shown for a time-series (±S.E. n = 6) of 23Na TQF and DQF spectra acquired in an interleaved fashion in the perfused mouse heart during stability and during sub-
sequent infusion of 50 μMouabain, shaded area. Representative TQF and DQF spectra are shown; (b) during stability, (c) after 20min infusion of ouabain, (d) after 20min K+-free buffer
and (e) after 20 min K+-free/Ca2+-free buffer.
99T.R. Eykyn et al. / Journal of Molecular and Cellular Cardiology 86 (2015) 95–101Fig. 6 shows intracellular [Na]i measured in a cohort of wild type
mice and in the PLM3SA transgenic model. Fig. 6(a) shows [Na]i mea-
sured with the shift reagent technique for the two groups, with a mea-
sured [Na]i = 15.7 ± 1.6 mM (n = 6) in the WT and [Na]i = 20.5 ±
1.4 mM (n = 6) in PLM3SA hearts (p = 0.04). For the same cohorts
and employing the calibration curve in Fig. 5, the TQF/DQF ratio was
RTQF/DQF = 2.79 ± 0.19 in the WT group with a derived value of
[Na]i = 13.7 ± 1.9 mM (n = 6) and RTQF/DQF = 2.95 ± 0.18 in the
PLM3SA group with a derived [Na]i = 15.3 ± 1.8 mM (n = 6) (p =
0.54). Despite the poorer signal-to-noise ratio in the multiple quantum
ﬁltered experiments the standard errors were only marginally greater
for the TQF/DQF ratio compared to shift reagent, reﬂecting similar
heart-to-heart variability of the two techniques. However the TQF/
DQF ratio did not measure a signiﬁcant difference in [Na]i using a
small n number. Using a larger pooled sample numbers the TQF/DQF
ratio was RTQF/DQF = 2.59 ± 0.09 in the WT group with a derived
value of [Na]i = 11.6 ± 0.9 mM (n = 37) and RTQF/DQF = 3.12 ± 0.180 10 20 30 40 50 60 70
[Na] mMi
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Fig. 5. Plot of the TQF/DQF ratio RTQF/DQF vs the measured concentration [Na]i in the per-
fused mouse heart at baseline (ﬁlled square, n = 6) and following a 20 min intervention
to elevate [Na]i; 50 μM ouabain (ﬁlled triangle, n = 6); 0 mM K+ (open diamond, n =
3), 0 mM K+/0 mM Ca2+ (ﬁlled circle, n = 3) and 0 mM K+/0 mM Ca2+/0 mM Mg2+
(open circle, n = 3). Mean data are shown for each group ± S.E.in the PLM 3SA group with a derived [Na]i = 17.0 ± 1.8 mM (n = 21)
(p= 0.024), Fig. 6(b). The TQF/DQF ratio required a larger pooled num-
ber of hearts to show a signiﬁcant difference between the groups. A
modest but signiﬁcant elevation of baseline [Na]i was measured in the
PLM3SA mouse compared to WT using both techniques.
4. Discussion
We have developed an MR-compatible Langendorff constant-
pressure/constant ﬂow perfusion system to non-invasively probe
mouse myocardial [Na]i at physiological heart rates and temperatures.
Multiple quantum ﬁltering techniques (DQF and TQF) were used to
monitor [Na]i during baseline physiological perfusion and during rela-
tive changes in [Na]i initiated by inhibition of the Na/K ATPase activity
by 50 μM ouabain and modiﬁed KH buffers (K+-free, K+-free/Ca2+-
free and K+-free/Ca2+-free/Mg2+-free KHB). Using the commonly
used shift reagent, Tm(DOTP)5− to distinguish the relative contribu-
tions to the MQF signal from intra [Na]i and extracellular [Na]e, we
were able to quantify [Na]i and thereby compare these to the measure-
ments obtained using the MQF experiments. In the presence of shift re-
agent we found that the proportion of the total TQF signal arising from
the extracellular [Na]e pool was approximately 32%, indicating that the
signal mainly represents [Na]i. We observed that the DQF signal was in-
dependent of elevations in [Na]i, consistentwith this signal arising from
the extracellular [Na]e pool. In both TQF and DQF multiple quantum ﬁl-
tered experiments the bulk isotropic Na signal isﬁltered out of the spec-
trum leaving only the Na pools subject to anisotropic interactions; the
TQF arising due to biexponential relaxation and macromolecular Na
binding in the intracellular matrix whilst the rank 2 DQF signal arises
due to a residual quadrupolar coupling due to association with ordered
structures such as tissueﬁbre orientation. The relative amplitudes of the
TQF and DQF signals, with the former being greater than the latter, rep-
resent the different anisotropic environments found in these different
compartments. We found a good correlation between the TQF/DQF
ratio RTQF/DQF and [Na]i and propose, therefore, that this ratio can be
used as a semi-quantitative measure of [Na]i in the mouse heart. Using
the DQF signal as an internal extracellular reference on a heart-by-
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Fig. 6. Plot of measured [Na]i in theWTmouse and PLM3SA transgenic mouse using (a) the shift reagent technique and (b) the derived values of [Na]i using the TQF/DQF ratio. Signiﬁcant
differences between the two groups are shown **p b 0.05.
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(data not shown), does not require an external [Na]ref standard for cal-
ibration and enables a direct measure of [Na]i without resorting to the
use of shift reagents.
Absolute quantiﬁcation of [Na]i is challenging, particularly in the
perfused mouse heart under physiological perfusion conditions. For
the calculation of intracellular volume we assume a value of 2.5 ml/g
dry weight of tissue which is adequate for the present control group
of hearts [20]. This value is also in close agreement with that of
0.44 ml/g wet weight estimated by Jelicks and Gupta [24]. However,
exact measurement of intracellular volume would be required if these
techniques are to be applied under conditionswhere this might change.
It must also be noted that a large proportion of the intracellular pool
may not be visible due to the quadrupolar nature of the intracellular
23Na+ bound to macromolecules. The NMR invisibility of a fraction of
the intracellular Na has been reported by some [25] whilst others
have reported that intracellular Na is 100% visible [24].
Whilst the extent of 23Na visibility may bias the absolute quantiﬁca-
tion of [Na]i using shift reagent [25], multiple quantumﬁltered 23Nawill
be useful to examine relative changes in [Na]i applied to perfusedmouse
hearts. Both shift reagent and the TQF/DQF ratiowere able to distinguish
similar baseline differences in [Na]i in the two groups of hearts. The
PLM3SA mouse displayed signiﬁcantly elevated [Na]i as measured both
by shift reagent and the TQF/DQF ratio. Despite the poorer signal-to-
noise ratio of the TQF and DQF NMR measurements compared to shift
reagent (Fig. 3) the standard errors in the measurements of [Na]i were
similar in magnitude for the two techniques and only slightly larger
for the TQF/DQF ratio, reﬂecting similar heart-to-heart variability. How-
ever there is a discrepancy in the absolute magnitude of the measured
[Na]i using the two techniques and a larger pooled sample size was re-
quired to reach signiﬁcance between the two groups employing the
TQF/DQF ratio. This may reﬂect the different measurement techniques
and possible errors introduced in the derivation of the calibration
curve aswell as the different perfusion conditions, the groupsmeasured
with shift reagent being non-contracting due to the Ca chelation effect
of the shift reagent whilst the TQF/DQF measurements are performed
under more physiological conditions as reﬂected by the stable ex vivo
cardiac function in Table 1. In future experiments, if absolute quantiﬁca-
tion of [Na]i is not required but relative changes with respect to baseline
then the % change in TQF signal alone could also be used, providing
there is no change in the DQF signal, and would also offer a viable and
more reproducible alternative to the TQF/DQF ratio proposed here.
Whilst the TQF/DQFmeasurements required a large n number to distin-
guish baseline differences in [Na]i, the methods developed and validat-
ed in our study do not require the use of shift reagent, thus are
performed under more physiological conditions, making our study
readily applicable to the study of [Na]i regulation in a wealth of trans-
genic models and muscle types with chronically altered [Na]i.Disclosures
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